Nanoparticle formulation of poly(e{open}-caprolactone-co-lactide)-d-α-tocopheryl polyethylene glycol 1000 succinate random copolymer for cervical cancer treatment

Polymer

Volumn 51, Issue 25, 2010, Pages 5952-5959

  Ma, Yuandong ^a   Huang, Laiqiang ^a   Song, Cunxian ^b   Zeng, Xiaowei ^c   Liu, Gan ^c   Mei, Lin ^a  

^a TSINGHUA UNIVERSITY   (China)

^b INSTITUTE OF BIOMEDICAL ENGINEERING   (China)

^c NANKAI UNIVERSITY   (China)

Author keywords

Nanoparticles; PCL PLA TPGS; Random copolymer

Indexed keywords

CHEMOTHERAPY; DISEASES; POLYETHYLENE GLYCOLS; POLYETHYLENES; RING OPENING POLYMERIZATION; SOLVENT EXTRACTION;

CERVICAL CANCER TREATMENT; CRITICAL PROBLEMS; NANOPARTICLE FORMULATION; PCL-PLA-TPGS; POLYMERIC MATRICES; RANDOM COPOLYMER; SIZE AND SIZE DISTRIBUTIONS; TOCOPHERYL POLYETHYLENE GLYCOL 1000 SUCCINATES;

NANOPARTICLES;

EID: 78649332632     PISSN: 00323861     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.polymer.2010.10.029     Document Type: Article

References (37)

1. Parkin D.M., Pisani P., Ferlay J. Cancer J Clin 1999, 49:33.
2. Kim K.Y. Nanomedicine: NBM 2007, 3:103.
3. Sahoo S.K., Parveen S., Panda J.J. Nanomedicine: NBM 2007, 3:20.
4. Vasir J.K., Labhasetwar V. Technol Cancer Res Treat 2005, 4:363.
5. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. J Control Release 2000, 65:271.
6. Bawarski W.E., Chidlowsky E., Bharali D.J., Mousa S.A. Nanomedicine: NBM 2008, 4:273.
7. Davda J., Labhasetwar V. Int J Pharm 2002, 233:51.
8. Brigger I., Dubernet C., Couvreur P. Adv Drug Deliv Rev 2002, 54:631.
9. Chang K.Y., Lee Y.D. Acta Biomater 2009, 5:1075.
10. Zhang Y., Tang L., Sun L., Bao J., Song C., Huang L., et al. Acta Biomater 2010, 6(6):2045.
11. Vert M. J Mater Sci Mater Med 2009, 20:437.
12. Li S., Garreau H., Vert M. J Mater Sci Mater Med 1990, 1:123.
13. Sun H., Mei L., Song C., Cui X., Wang P. Biomaterials 2006, 27:1735.
14. Pitt C.G. Poly(e{open}-caprolactone) and its copolymers. Biodegradable polymers as drug delivery systems 1990, 71-120. Marcel Dekker, New York. M. Chasin, R. Langer (Eds.).
15. Li X., Wu Q., Chen Z., Gong X., Lin X. Polymer 2008, 49:4769.
16. Ma Y., Zheng Y., Liu K., Tian G., Tian Y., Xu L., et al. Nanoscale Res Lett 2010, 5(7):1161-1169.
17. Fischer J.R., Harkin K.R., Freeman L.C. Vet Tech Res Appl Vet Med 2002, 3:465.
18. Dintaman J.M., Silverman J.A. Pharm Res 1999, 16:1550.
19. Yu L., Bridgers A., Polli J., Vicker A., Long S., Roy A., et al. Pharm Res 1999, 16:1812.
20. Youk H.J., Lee E., Choi M.K., Lee Y.J., Chung J.H., Kim S.H., et al. J Control Release 2005, 107:43.
21. Constantinou C., Papas A., Constantinou A.I. Int J Cancer 2008, 123:739.
22. Neuzil J., Tomasetti M., Zhao Y., Dong L.F., Birringer M., Wang X.F., et al. Mol Pharmacol 2007, 71:1185.
23. Feng S.S., Mei L., Anitha P., Gan C.W., Zhou W. Biomaterials 2009, 30:3297.
24. Huang M.H., Suming L., Coudane J., Vert M. Macrom Chem Phy 2003, 204:1994.
25. Pamula E., Blazewicza M., Paluszkiewiczb Cz, Dobrzynski P. J Mol Struct 2001, 596:69.
26. Lin W.J., Lee H.G. J Control Release 2003, 89:179.
27. Liu K., Kiran E. Polymer 2008, 49:1555.
28. Li S.H., Woo E.M. Colloid Polym Sci 2008, 286:253.
29. Elzein T., Nasser-Eddine M., Delaite C., Bistac S., Dumas P. J Colloid Interface Sci 2004, 273:381.
30. Mosmann T. J Immunol Methods 1983, 65:55.
31. Neuzil J. Br J Cancer 2003, 89:1822.
32. Birringer M., EyTina J.H., Salvatore B.A., Neuzil J. Br J Cancer 2003, 88:1948.
33. Momot K.I., Kuchel P.W., Chapman B.E., Deo P., Whittaker D. Langmuir 2003, 19:2088.
34. Schroder H., Netscher T. Magn Reson Chem 2001, 39:701.
35. Win K.Y., Feng S.S. Biomaterials 2005, 26:2713.
36. Mei L., Zhang Y., Zheng Y., Tian G., Song C., Yang D., et al. Nanoscale Res Lett 2009, 4:1530-1539.
37. Raymond E., Hanauske A., Faivre S., Izbicka E., Clark G., Rowinsky E.K. Anticancer Drugs 1997, 8:379.